---
schema_version: '1.0'
id: news-20260818-531b0b
title: 非複製型HSVベクター活用する仏Cyllene社、シリーズCラウンドで3300万ユーロを調達
url: https://bio.nikkeibp.co.jp/atcl/news/p1/26/08/09/14878/
url_hash: 531b0b3f75885f9983117c8aba2f3d809a4d95e3929f7878bb3ba67f468fcf3f
canonical_url: https://bio.nikkeibp.co.jp/atcl/news/p1/26/08/09/14878
source: bio.nikkeibp.co.jp
category: news/business
category_raw: biz
region: null
tags:
- biz
- biotech
- venture_capital
- pharma
lang: null
published_at: null
fetched_at: '2026-08-18T14:02:41.177395Z'
updated_at: '2026-08-20T20:17:08.562294Z'
status: published
content_hash: null
content_changed_at: null
license_note: link-only
summary: null
summary_source: null
summary_en: null
summary_omitted_reason: license_restricted
redistribution: false
keywords_en:
- Big Pharma
- biotech
- biz
- biz_general
- Cyllene
- general news
- HSV
- pharma
- venture_capital
entities_en:
- name: Big Pharma
  type: organization
- name: biz_general
  type: content
topics_en:
- general news
numeric_facts: []
entities:
- name: Big Pharma
  type: organization
key_facts: []
related: []
related_auto:
- name: Trump
  type: person
  weight: 2.0
computed_at: null
sanitized_at: '2026-08-20T14:56:50.092484+00:00'
---

# 非複製型HSVベクター活用する仏Cyllene社、シリーズCラウンドで3300万ユーロを調達

## TL;DR
（要約なし・原文はリンク先を参照 / No summary available; see the source link.）

## Key Points
- biz / biotech / venture_capital / pharma

## Details
(本文なし。リンク先参照)

## Source
元記事: [非複製型HSVベクター活用する仏Cyllene社、シリーズCラウンドで3300万ユーロを調達](https://bio.nikkeibp.co.jp/atcl/news/p1/26/08/09/14878/)